Wealthfront’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $1.42M | Buy |
18,382
+1,193
| +7% | +$92.1K | 0.01% | 191 |
|
|
2018
Q2 | $1.22M | Sell |
17,189
-10,264
| -37% | -$727K | 0.01% | 212 |
|
|
2018
Q1 | $2.07M | Buy |
27,453
+5,974
| +28% | +$450K | 0.02% | 131 |
|
|
2017
Q4 | $1.54M | Sell |
21,479
-1,786
| -8% | -$128K | 0.02% | 154 |
|
|
2017
Q3 | $1.89M | Buy |
23,265
+13,007
| +127% | +$1.05M | 0.02% | 118 |
|
|
2017
Q2 | $726K | Buy |
10,258
+102
| +1% | +$7.22K | 0.01% | 204 |
|
|
2017
Q1 | $690K | Buy |
10,156
+865
| +9% | +$58.8K | 0.01% | 172 |
|
|
2016
Q4 | $665K | Sell |
9,291
-6,033
| -39% | -$432K | 0.01% | 153 |
|
|
2016
Q3 | $1.21M | Buy |
15,324
+913
| +6% | +$72.2K | 0.03% | 91 |
|
|
2016
Q2 | $1.2M | Sell |
14,411
-6,941
| -33% | -$579K | 0.03% | 86 |
|
|
2016
Q1 | $1.96M | Buy |
21,352
+3,750
| +21% | +$344K | 0.06% | 60 |
|
|
2015
Q4 | $1.78M | Sell |
17,602
-631
| -3% | -$63.8K | 0.06% | 57 |
|
|
2015
Q3 | $1.79M | Buy |
18,233
+3,005
| +20% | +$295K | 0.07% | 54 |
|
|
2015
Q2 | $1.78M | Buy |
15,228
+5,848
| +62% | +$685K | 0.07% | 36 |
|
|
2015
Q1 | $920K | Buy |
9,380
+1,403
| +18% | +$138K | 0.04% | 42 |
|
|
2014
Q4 | $752K | Sell |
7,977
-481
| -6% | -$45.3K | 0.04% | 49 |
|
|
2014
Q3 | $900K | Buy |
8,458
+2,412
| +40% | +$257K | 0.06% | 37 |
|
|
2014
Q2 | $531K | Buy |
6,046
+4,963
| +458% | +$436K | 0.05% | 38 |
|
|
2014
Q1 | $80K | Buy |
+1,083
| New | +$80K | 0.01% | 172 |
|